August 5, 2026: Inventurus Knowledge Solutions Limited (IKS Health) reported robust financial performance for the first quarter of FY2026-27, posting double-digit growth in revenue, EBITDA, and profit after tax, supported by strong client demand, operational efficiency, and continued expansion of its AI-enabled healthcare platform.
The healthcare technology company announced its financial results for the quarter ended June 30, 2026, highlighting sustained momentum across its business and reaffirming its long-term growth strategy following the acquisition of TruBridge.
IKS Health Q1 FY27 Financial Performance
For the quarter ended June 30, 2026, IKS Health reported:
- Revenue: ₹893.6 crore (₹8,936 million), up 20.7% YoY
- EBITDA: ₹294.9 crore (₹2,949 million), up 24% YoY
- EBITDA Margin: 33%
- Profit After Tax (PAT): ₹193.7 crore (₹1,937 million), up 27.8% YoY
- PAT Margin: 21.7%
- Adjusted PAT: ₹215.3 crore (₹2,153 million), up 28% YoY, with a margin of 24.1%
In U.S. dollar terms, quarterly revenue increased 12% year-on-year, reflecting healthy business expansion across international markets.
Management Commentary
Sachin K. Gupta, Founder & Global CEO of IKS Health, said the company’s performance demonstrates the strength of its scalable healthcare platform and long-term growth strategy.
He noted that the recently announced TruBridge acquisition represents a significant milestone, expanding IKS Health’s capabilities and strengthening its presence among rural and community healthcare providers in the United States.
Group CFO Nithya Balasubramanian said the company delivered strong financial performance through disciplined cost management, operational efficiency, and capital allocation while continuing to invest in strategic growth initiatives.
AI-Led Healthcare Platform Driving Growth
IKS Health continues to expand its Care Enablement Platform, which combines:
- Agentic AI workflows
- Human healthcare expertise
- Revenue cycle management solutions
- Clinical documentation support
- Patient engagement technologies
- Operational workflow automation
The company said the platform helps hospitals, physician groups, specialty practices, and healthcare systems improve operational efficiency while enhancing patient care delivery.
Recognition and Awards
During the quarter, IKS Health received several industry recognitions, including:
- U.S. patent for its AI-powered Engagement Learning Engine (AAW behavioral modeling)
- 2026 Dallas-Fort Worth Titan 100 recognition for Founder & CEO Sachin K. Gupta
- Best CFO & Finance Strategy Excellence Awards 2026
- FE HR Awards 2026 for Excellence in Onboarding and Role Enablement
- American Medical Group Association (AMGA) Distinguished Corporate Partner Award 2026
Focus on Long-Term Growth
The company said it remains focused on protecting margins while investing in technology, AI capabilities, and platform scalability to support sustainable long-term growth.
Following its listing on the NSE and BSE in December 2024, IKS Health has continued strengthening its position as a global healthcare technology provider serving major healthcare organizations across the United States.
Key Q1 FY27 Highlights
| Metric | Q1 FY27 | YoY Growth |
|---|---|---|
| Revenue | ₹893.6 crore | +20.7% |
| EBITDA | ₹294.9 crore | +24% |
| EBITDA Margin | 33% | — |
| PAT | ₹193.7 crore | +27.8% |
| PAT Margin | 21.7% | — |
| Adjusted PAT | ₹215.3 crore | +28% |
